Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Opinion

Plain and simple. You can argue all you want, but our problems arose when we signed that commericalization agreement with TPL. It allowed PTSC the luxury of sitting silent by having an excuse to not communicate effectively with investors. Does anyone believe that the ramifications of doing this were not known and discussed by our board. Apparently Swartz didn't want to be in for the long ride and he was totally accomidated. Also when the courts agree to keep settlement details through non-disclosure agreements it would seem the cards are stacked against investors. What is legal is not always what is right. How is the J3 settlement not a significant event requiring a 8K filing? How can the details not be given factually to investors? ie, "all parties are happy" and etc.

I sold my stock at .13 because of that CA. But when they pumped the hell out of the fujitsu deal and their umbrella theories I got back in at .40. Always trust your gut feelings over your trust in lawyers.

Share
New Message
Please login to post a reply